To the full analysis
Virbac stock: growth
VIRP.PAVirbac reported $1.62B in revenue for fiscal 2025, up 4.8% on the prior year, up 9.4% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
7%
per year from 2006 to 2025, per share 7.2%
Earnings (Annual rate)
9.9%
per year from 2006 to 2025, per share 10.1%
Free cash flow (Annual rate)
5.6%
per year from 2006 to 2025, per share 5.7%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 9.4% | 5.6% | 7.0% |
| Revenue per share | 9.5% | 5.6% | 7.2% |
| Earnings | 2.1% | 32.0% | 9.9% |
| Earnings per share | 2.2% | 32.0% | 10.1% |
| Free cash flow | 4.9% | 27.4% | 5.6% |
| Free cash flow per share | 5.1% | 27.4% | 5.7% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $445.05M | $27.61M | $40.54M |
| 2007 | $485.96M | $35.32M | $37.23M |
| 2008 | $491.28M | $40.21M | $26.22M |
| 2009 | $517.95M | $43.96M | $47.18M |
| 2010 | $634.75M | $71.27M | $65.34M |
| 2011 | $690.41M | $64.88M | $20.46M |
| 2012 | $770.3M | $73.83M | $67.77M |
| 2013 | $815.65M | $67.07M | $20.87M |
| 2014 | $856.69M | $70.47M | $45.17M |
| 2015 | $944.79M | $10.42M | $10.2M |
| 2016 | $966.07M | $38.39M | $119.75M |
| 2017 | $955.05M | −$2.85M | $84.51M |
| 2018 | $962.86M | $22.27M | $64.05M |
| 2019 | $1.04B | $57.12M | $127.31M |
| 2020 | $1.04B | $150.74M | $90.01M |
| 2021 | $1.18B | $125.39M | $87.68M |
| 2022 | $1.35B | $135.15M | $50.32M |
| 2023 | $1.38B | $134.41M | $85.99M |
| 2024 | $1.55B | $161M | $149.57M |
| 2025 | $1.62B | $167.2M | $114.59M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 1 May 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.